微创心通医疗科技有限公司（02160）于2026年3月5日发布截至2026年2月28日的股份变动月报表。报告显示，公司本月完成股份合并，股本结构及已发行股份总数相应调整。
报告期内，公司法定注册股本维持50,000美元不变，普通股的登记数量由上月底的10,000,000,000股降至2,000,000,000股，面值由每股0.000005美元调整为每股0.000025美元。
截至2月底，公司已发行股份由上月底的6,366,557,195股减少至1,273,311,439股，减少数量为5,093,245,756股，主要原因是公司按每五股合并为一股的基准实施了股份合并。公司在报告期内无新增发行、购回或注销库存股事宜。
同时，公司根据已披露的股份期权和股份计划，对部分购股权进行注销及调整，期末可能行使或转让的基础股份数量相应减少。期间未涉及可换股票据或其他融资工具的变动。
公司指出，以上变动均符合香港联合交易所有限公司的上市规则及相关法律规定。本次月报由联席公司秘书李香梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.